Biggest News Aggregation in the World
📰 Ife Forms News

Page 199 - Ife Forms News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ife Forms. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

UK becomes first to authorize Merck and Ridgeback Biotherapeutics' antiviral molnupiravir to treat mild-to-moderate Covid-19

The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe
United Kingdom Ridgeback Biotherapeutic Scott Gottlieb Anderson Cooper Gilead Sciences Emory University
Source: kvoa.com

UK becomes first to authorize Merck and Ridgeback Biotherapeutics' antiviral molnupiravir to treat mild-to-moderate Covid-19

The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe
United Kingdom Ridgeback Biotherapeutic Scott Gottlieb Anderson Cooper Gilead Sciences Emory University

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science